Finding 1181741 (2025-002)

Material Weakness Repeat Finding
Requirement
C
Questioned Costs
-
Year
2025
Accepted
2026-03-20

AI Summary

  • Core Issue: Internal controls were inadequate, leading to delays in subrecipient payments beyond the required 30 days.
  • Impacted Requirements: Noncompliance with 2 CFR 200.303(a) and 2 CFR 200.305(b)(3) regarding timely reimbursement of federal awards.
  • Recommended Follow-Up: Management should implement stronger controls and monitor processes to ensure compliance with the 30-day payment requirement.

Finding Text

Assistance Listing, Federal Agency, and Program Name - 93.837, U.S. Department of Health and Human Services, Cardiovascular Disease Research (Research and Development Cluster) Federal Award Identification Number and Year - 93.837 - U01HL146245 (2024) Pass through Entity - N/A Finding Type - Material weakness and material noncompliance with laws and regulations Repeat Finding - No Criteria - Per 2 CFR 200.303(a), nonfederal entities must establish and maintain effective internal controls over the federal award that provides reasonable assurance that the nonfederal entity is managing the federal award in compliance with federal statutes, regulations, and the terms and conditions of the federal award. These internal controls should be in compliance with the guidance in Standards for Internal Control in the Federal Government, issued by the Comptroller General of the United States, or the Internal Control Framework, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Per 2 CFR 200.305(b)(3), when the reimbursement method is used, the Federal agency or pass through entity must make payment within 30 calendar days after receipt of the payment request unless the Federal agency or pass through entity reasonably believes the request to be improper. Condition - Controls in place were not sufficient to ensure subrecipients were paid consistently within 30 days of a request for reimbursement. Questioned Costs - N/A If questioned costs are not determinable, description of why known questioned costs were undetermined or otherwise could not be reported - N/A Identification of How Questioned Costs Were Computed - N/A Context - Out of a sample of 29 subrecipient disbursements tested, we noted 6 were not paid within 30 days of the LLC receiving the request for reimbursement. Cause and Effect - A lack of effective internal controls resulted in material noncompliance with this requirement. Recommendation - We recommend management establish robust controls over subrecipient activity to ensure the 30 day requirement is met. Views of Responsible Officials and Planned Corrective Actions - Management acknowledges the finding. Delays in approvals may occur due to multiple internal and external parties involved. To prevent recurrence, management will monitor all parties, issue email reminders with clear deadlines, and enforce timely processing to ensure compliance with the 30 day requirement.

Corrective Action Plan

Condition: Controls in place were not sufficient to ensure subrecipients were paid consistently within 30 days of a request for reimbursement. Planned Corrective Action: Management acknowledges the finding. Delays in approvals may occur due to multiple internal and external parties involved. To prevent recurrence, management will monitor all parties, issue email reminders with clear deadlines, and enforce timely processing to ensure compliance with the 30-day requirement. Contact person responsible for corrective action: Teresa Martinez, Lorena Soto, Alvaro Espino and Mariela Romo Anticipated Completion Date: 8/31/2026

Categories

Subrecipient Monitoring Cash Management Material Weakness Matching / Level of Effort / Earmarking Internal Control / Segregation of Duties

Other Findings in this Audit

  • 1181730 2025-001
    Material Weakness Repeat
  • 1181731 2025-001
    Material Weakness Repeat
  • 1181732 2025-001
    Material Weakness Repeat
  • 1181733 2025-001
    Material Weakness Repeat
  • 1181734 2025-001
    Material Weakness Repeat
  • 1181735 2025-001
    Material Weakness Repeat
  • 1181736 2025-001
    Material Weakness Repeat
  • 1181737 2025-001
    Material Weakness Repeat
  • 1181738 2025-001
    Material Weakness Repeat
  • 1181739 2025-001
    Material Weakness Repeat
  • 1181740 2025-001
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.837 CARDIOVASCULAR DISEASES RESEARCH $1.45M
93.592 FAMILY VIOLENCE PREVENTION AND SERVICES/DISCRETIONARY $945,665
93.323 EPIDEMIOLOGY AND LABORATORY CAPACITY FOR INFECTIOUS DISEASES (ELC) $693,668
93.088 ADVANCING SYSTEM IMPROVEMENTS FOR KEY ISSUES IN WOMEN'S HEALTH $687,401
93.592 COVID-19 - FAMILY VIOLENCE PREVENTION AND SERVICES/DISCRETIONARY $678,578
93.399 CANCER CONTROL $530,856
93.153 COORDINATED SERVICES AND ACCESS TO RESEARCH FOR WOMEN, INFANTS, CHILDREN, AND YOUTH $488,474
93.918 GRANTS TO PROVIDE OUTPATIENT EARLY INTERVENTION SERVICES WITH RESPECT TO HIV DISEASE $264,284
93.994 MATERNAL AND CHILD HEALTH SERVICES BLOCK GRANT TO THE STATES $170,864
93.914 HIV EMERGENCY RELIEF PROJECT GRANTS $45,538
93.855 CARDIOVASCULAR DISEASES RESEARCH $31,529
14.241 HOUSING OPPORTUNITIES FOR PERSONS WITH AIDS $26,240
93.395 CANCER TREATMENT RESEARCH $18,176
93.686 ENDING THE HIV EPIDEMIC: A PLAN FOR AMERICA — RYAN WHITE HIV/AIDS PROGRAM PARTS A AND B $13,330
93.940 HIV PREVENTION ACTIVITIES HEALTH DEPARTMENT BASED $13,085
93.917 HIV CARE FORMULA GRANTS $11,125
16.526 OVW TECHNICAL ASSISTANCE INITIATIVE $10,086
93.110 MATERNAL AND CHILD HEALTH FEDERAL CONSOLIDATED PROGRAMS $4,057